Molecular Endocrinology, Vol 9, 628-636, Copyright © 1995 by Endocrine Society

ARTICLES

Differential biallelic activation of three insulin-like growth factor II promoters in the mouse central nervous system

JF Hu, TH Vu and AR Hoffman
Medical Service, Veterans Affairs Medical Center, Palo Alto, California, USA.

Imprinting of the insulin-like growth factor II gene (IGF-II) is conserved in human, rat, and mouse. In human liver and chondrocytes, IGF-II transcripts from promoter hP1 are always derived from both parental alleles, while transcripts from promoters hP2-hP4 are from one parental allele. To examine the promoter-specific imprinting pattern of mouse IGF-II, we examined IGF-II expression in F1 generation mice derived from crossing M. spretus with M. musculus using a novel BsaA1 polymorphism in mouse IGF-II exon 6. There was maintenance of maternal IGF-II imprinting in all non-central nervous system (CNS) tissues in the F1 generation animals. However, there was biallelic expression of the IGF-II gene in CNS. Allelic expression of each IGF-II promoter transcript was examined by full-length cDNA amplification with promoter- specific primers. In every tissue in which IGF-II was imprinted, IGF-II transcripts were derived from paternal promoters mP1-mP3, while the maternal allele was suppressed. In the CNS, however, promoters mP1-mP3 of the imprinted maternal allele became activated, leading to the biallelic expression of IGF-II. Moreover, the expression of IGF-II from each parental allele differed in various CNS regions. In leptomeninges, mP1-mP3 drive IGF-II expression predominantly from the paternal allele, while in some CNS regions, the promoter transcripts were primarily from the maternal allele. The coordinate regulation of mouse IGF-II promoters suggests the presence of an upstream imprinting complex controlling IGF-II imprinting.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				V. P. Kovacheva, T. J. Mellott, J. M. Davison, N. Wagner, I. Lopez-Coviella, A. C. Schnitzler, and J. K. Blusztajn Gestational Choline Deficiency Causes Global and Igf2 Gene DNA Hypermethylation by Up-regulation of Dnmt1 Expression J. Biol. Chem., October 26, 2007; 282(43): 31777 - 31788. [Abstract] [Full Text] [PDF]

				S. V. Dindot, P. W. Farin, C. E. Farin, J. Romano, S. Walker, C. Long, and J. A. Piedrahita Epigenetic and Genomic Imprinting Analysis in Nuclear Transfer Derived Bos gaurus/Bos taurus Hybrid Fetuses Biol Reprod, August 1, 2004; 71(2): 470 - 478. [Abstract] [Full Text] [PDF]

				X. Yao, J.-F. Hu, M. Daniels, H. Yien, H. Lu, H. Sharan, X. Zhou, Z. Zeng, T. Li, Y. Yang, et al. A Novel Orthotopic Tumor Model to Study Growth Factors and Oncogenes in Hepatocarcinogenesis Clin. Cancer Res., July 1, 2003; 9(7): 2719 - 2726. [Abstract] [Full Text] [PDF]

				J.-F. Hu, J. Pham, I. Dey, T. Li, T. H. Vu, and A. R. Hoffman Allele-Specific Histone Acetylation Accompanies Genomic Imprinting of the Insulin-Like Growth Factor II Receptor Gene Endocrinology, December 1, 2000; 141(12): 4428 - 4435. [Abstract] [Full Text] [PDF]

				J.-F. Hu, H. Oruganti, T. H. Vu, and A. R. Hoffman Tissue-Specific Imprinting of the Mouse Insulin-Like Growth Factor II Receptor Gene Correlates with Differential Allele-Specific DNA Methylation Mol. Endocrinol., February 1, 1998; 12(2): 220 - 232. [Abstract] [Full Text]

				J.-F. Hu, P. H. Nguyen, N. V. Pham, T. H. Vu, and A. R. Hoffman Modulation of Igf2 Genomic Imprinting in Mice Induced by 5-Azacytidine, an Inhibitor of DNA Methylation Mol. Endocrinol., December 1, 1997; 11(13): 1891 - 1898. [Abstract] [Full Text] [PDF]

				H.-X. Zhuang, L. Wuarin, Z.-J. Fei, and D. N. Ishii Insulin-Like Growth Factor (IGF) Gene Expression Is Reduced in Neural Tissues and Liver from Rats with Non-Insulin-Dependent Diabetes Mellitus, and IGF Treatment Ameliorates Diabetic Neuropathy J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 366 - 374. [Abstract] [Full Text]

				J.-F. Hu, T. H. Vu, and A. R. Hoffman Genomic Deletion of an Imprint Maintenance Element Abolishes Imprinting of Both Insulin-like Growth Factor II and H19 J. Biol. Chem., August 15, 1997; 272(33): 20715 - 20720. [Abstract] [Full Text] [PDF]

				W.-H. Wang, J.-X. Duan, T. H. Vu, and A. R. Hoffman Increased Expression of the Insulin-like Growth Factor-II Gene in Wilms' Tumor Is Not Dependent on Loss of Genomic Imprinting or Loss of Heterozygosity J. Biol. Chem., November 1, 1996; 271(44): 27863 - 27870. [Abstract] [Full Text] [PDF]

				J.-F. Hu, T. H. Vu, and A. R. Hoffman Promoter-specific Modulation of Insulin-like Growth Factor II Genomic Imprinting by Inhibitors of DNA Methylation J. Biol. Chem., July 26, 1996; 271(30): 18253 - 18262. [Abstract] [Full Text] [PDF]

				T. H. Vu and A. R. Hoffman Alterations in the Promoter-specific Imprinting of the Insulin-like Growth Factor-II Gene in Wilms' Tumor J. Biol. Chem., April 12, 1996; 271(15): 9014 - 9023. [Abstract] [Full Text] [PDF]

				S. Zhan, D. Shapiro, S. Zhan, L. Zhang, S. Hirschfeld, J. Elassal, and L. J. Helman Concordant Loss of Imprinting of the Human Insulin-like Growth Factor II Gene Promoters in Cancer J. Biol. Chem., November 24, 1995; 270(47): 27983 - 27986. [Abstract] [Full Text] [PDF]